{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:47:34Z","timestamp":1777045654448,"version":"3.51.4"},"reference-count":47,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"3_Suppl","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,3]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n<jats:p>Haiti is endemic for lymphatic filariasis (LF) and malaria, two mosquito-transmitted parasitic diseases targeted for elimination. The World Health Organization recommends a transmission assessment survey (TAS-1) to determine if LF prevalence is significantly beneath putative transmission thresholds (&lt;2% antigen prevalence in Haiti, where <jats:italic>Culex<\/jats:italic> is the primary vector for <jats:italic>Wuchereria bancrofti<\/jats:italic>) to stop mass drug administration (MDA). Repeated TASs (TAS-2 and TAS-3) are recommended at 2\u20133-year intervals during post-treatment surveillance. From 2017 to 2022, The Carter Center assisted the Haitian Ministry of Public Health and Population in conducting 15 TASs in 11 evaluation units (EUs) encompassing 54 of the country\u2019s 146 districts. Children 6\u20137 years old were assessed for circulating filarial antigen (CFA) by Filariasis Test Strip: <jats:italic>n<\/jats:italic> = 5,239 in TAS-1; <jats:italic>n<\/jats:italic> = 11,866 in TAS-2; and <jats:italic>n<\/jats:italic> = 1,842 in TAS-3, of whom eight (0.15%), 20 (0.17%), and eight (0.43%) tested positive, respectively. The number of positive results in children was less than the threshold in each EU. When available, participants (<jats:italic>n<\/jats:italic> = 16,663) were also tested for malaria by rapid diagnostic test, with 31 (0.19%) children testing positive for <jats:italic>Plasmodium falciparum<\/jats:italic>. Integrated TASs provided an efficient means to collect epidemiological data for LF and malaria in Haiti. Results indicated thresholds for stopping and maintaining the halt of MDA for LF have been achieved in all EUs, with the halt of MDA for 571,358 people in four districts and the first TAS-3 surveys conducted in Haiti. Investigations are needed to assess the potential of ongoing LF transmission, especially in areas where CFA-positive samples were detected in TAS-3.<\/jats:p>","DOI":"10.4269\/ajtmh.23-0765","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T13:32:07Z","timestamp":1719322327000},"page":"81-88","source":"Crossref","is-referenced-by-count":3,"title":["Results of Integrated Transmission Assessment Surveys for Lymphatic Filariasis and Malaria in Haiti, 2017\u20132022"],"prefix":"10.4269","volume":"111","author":[{"given":"Lucc\u00e8ne","family":"D\u00e9sir","sequence":"first","affiliation":[{"name":"The Carter Center, Atlanta, Georgia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen E. S.","family":"Hamre","sequence":"additional","affiliation":[{"name":"The Carter Center, Atlanta, Georgia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9ry Madsen","family":"Beau De Rochars","sequence":"additional","affiliation":[{"name":"The Carter Center, Atlanta, Georgia;"},{"name":"The Emerging Pathogens Institute and Department of Health Services Research, Management and Policy, University of Florida, Gainesville, Florida;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean F.","family":"Lemoine","sequence":"additional","affiliation":[{"name":"Minist\u00e8re de la Sant\u00e9 Publique et de la Population, Port-au-Prince, Haiti"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Aur\u00e8le","family":"Telfort","sequence":"additional","affiliation":[{"name":"Minist\u00e8re de la Sant\u00e9 Publique et de la Population, Port-au-Prince, Haiti"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory S.","family":"Noland","sequence":"additional","affiliation":[{"name":"The Carter Center, Atlanta, Georgia;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"b1","series-title":"World Malaria Report 2023","year":"2023"},{"key":"b2","series-title":"Wkly Epidemiol Rec","first-page":"489","article-title":"Global Programme to eliminate lymphatic filariasis: Progress report 2022","volume":"41","year":"2023"},{"key":"b3","series-title":"Wkly Epidemiol Rec","first-page":"25","article-title":"Meeting of the International Task Force for Disease Eradication \u2013 12 May 2006","volume":"82","year":"2007"},{"key":"b4","series-title":"Wkly Epidemiol Rec","first-page":"149","article-title":"Lymphatic filariasis","volume":"76","year":"2001"},{"key":"b5","series-title":"Lancet","first-page":"480","article-title":"Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children","volume":"350","author":"Addiss","year":"1997"},{"key":"b6","series-title":"Trans R Soc Trop Med Hyg","first-page":"94","article-title":"Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis","volume":"92","author":"Ismail","year":"1998"},{"key":"b7","series-title":"Monitoring and Epidemiological Assessment of Mass Drug Administration in the Global Programme to Eliminate Lymphatic Filariasis: A Manual for National Elimination Programmes","year":"2011"},{"key":"b8","series-title":"PLoS Negl Trop Dis","first-page":"e0008298","article-title":"Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study","volume":"14","author":"Dubray","year":"2020"},{"key":"b9","series-title":"N Engl J Med","first-page":"1956","article-title":"Single-dose triple-drug therapy for Wuchereria bancrofti \u2013 5-Year Follow-Up","volume":"382","author":"King","year":"2020"},{"key":"b10","series-title":"MMRW Recomm Rep","first-page":"1","article-title":"Recommendations of the International Task Force for Disease Eradication","volume":"42","year":"1993"},{"key":"b11","year":"1997"},{"key":"b12","year":"2023"},{"key":"b13","series-title":"Int Health","first-page":"S33","article-title":"Progress towards elimination of lymphatic filariasis in the Americas region","volume":"13","author":"Fontes","year":"2021"},{"key":"b14","series-title":"PLoS Negl Trop Dis","first-page":"e0009590","article-title":"Lymphatic filariasis elimination in the Dominican Republic: History, progress, and remaining steps","volume":"15","author":"Gonzales","year":"2021"},{"key":"b15","series-title":"Am J Trop Med Hyg","first-page":"598","article-title":"Geographic distribution of lymphatic filariasis in Haiti","volume":"71","author":"Beau de Rochars","year":"2004"},{"key":"b16","series-title":"PLoS Negl Trop Dis","first-page":"e1807","article-title":"Secondary mapping of lymphatic filariasis in Haiti: Definition of transmission foci in low-prevalence settings","volume":"6","author":"Drexler","year":"2012"},{"key":"b17","series-title":"PLoS Negl Trop Dis","first-page":"e0004954","article-title":"Controlling neglected tropical diseases (NTDs) in Haiti: Implementation strategies and evidence of their success","volume":"10","author":"Lemoine","year":"2016"},{"key":"b18","series-title":"PLoS Negl Trop Dis","first-page":"e2915","article-title":"Haiti National Program for the elimination of lymphatic filariasis\u2014A model of success in the face of adversity","volume":"8","author":"Oscar","year":"2014"},{"key":"b19","series-title":"Global Technical Strategy for Malaria 2016\u20132030, 2021 Update","year":"2021"},{"key":"b20","series-title":"Am J Trop Med Hyg","first-page":"43","article-title":"Haiti\u2019s commitment to malaria elimination: Progress in the face of challenges, 2010\u20132016","volume":"97","author":"Lemoine","year":"2017"},{"key":"b21","series-title":"Malar J","first-page":"237","article-title":"Malaria elimination in Haiti by the year 2020: An achievable goal?","volume":"14","author":"Boncy","year":"2015"},{"key":"b22","series-title":"Wkly Epidemiol Rec","first-page":"75","article-title":"Meeting of the International Task Force for Disease Eradication \u2013 November 2012","volume":"88","year":"2013"},{"key":"b23","series-title":"A Framework for Malaria Elimination","year":"2017"},{"key":"b24","series-title":"Preparing for Certification of Malaria Elimination, Second Edition","year":"2022"},{"key":"b25","series-title":"Malar J","first-page":"376","article-title":"Malaria vector research and control in Haiti: A systematic review","volume":"15","author":"Frederick","year":"2016"},{"key":"b26","series-title":"Am J Trop Med Hyg","first-page":"258","article-title":"Spatial clustering and risk factors for malaria infections and marker of recent exposure to Plasmodium falciparum from a household survey in Artibonite, Haiti","volume":"109","author":"Hamre","year":"2023"},{"key":"b27","series-title":"\u00c9tude TRaC sur la Possession et l\u2019Utilisation des Moustiquaires Impr\u00e9gn\u00e9es d\u2019Insecticides et la Pr\u00e9valence du Paludisme en Ha\u00efti","year":"2011"},{"key":"b28","series-title":"\u00c9tude Comportementale et \u00c9pid\u00e9miologique Aupr\u00e8s des M\u00e9nages sur le Paludisme en Ha\u00efti, 2015","year":"2015"},{"key":"b29","series-title":"Malar J","first-page":"462","article-title":"PET-PCR method for the molecular detection of malaria parasites in a national malaria surveillance study in Haiti, 2011","volume":"13","author":"Lucchi","year":"2014"},{"key":"b30","series-title":"Trop Med Int Health","first-page":"1030","article-title":"Submicroscopic malaria infections in pregnant women from six departments in Haiti","volume":"22","author":"Elbadry","year":"2017"},{"key":"b31","series-title":"Malar J","first-page":"510","article-title":"High prevalence of asymptomatic malaria infections: A cross-sectional study in rural areas in six departments in Haiti","volume":"14","author":"Elbadry","year":"2015"},{"key":"b32","series-title":"PLoS Negl Trop Dis","first-page":"e0005387","article-title":"Partnering for impact: Integrated transmission assessment surveys for lymphatic filariasis, soil transmitted helminths and malaria in Haiti","volume":"11","author":"Knipes","year":"2017"},{"key":"b33","year":"2015"},{"key":"b34","series-title":"Stata Statistical Software: Release 16","year":"2019"},{"key":"b35","series-title":"PLoS Negl Trop Dis","first-page":"e0005914","article-title":"Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration","volume":"11","author":"Lau","year":"2017"},{"key":"b36","series-title":"PLoS Negl Trop Dis","first-page":"e0006583","article-title":"Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance \u2013 American Samoa, 2016","volume":"12","author":"Sheel","year":"2018"},{"key":"b37","series-title":"PLoS Negl Trop Dis","first-page":"e0006066","article-title":"Reassessment of areas with persistent lymphatic filariasis nine years after cessation of mass drug administration in Sri Lanka","volume":"11","author":"Rao","year":"2017"},{"key":"b38","series-title":"Am J Trop Med Hyg","first-page":"735","article-title":"Comprehensive assessment of a hotspot with persistent bancroftian filariasis in coastal Sri Lanka","volume":"99","author":"Rao","year":"2018"},{"key":"b39","series-title":"PLoS Negl Trop Dis","first-page":"e0003669","article-title":"Cessation of mass drug administration for lymphatic filariasis in Zanzibar in 2006: Was transmission interrupted?","volume":"9","author":"Rebollo","year":"2015"},{"key":"b40","series-title":"BMC Biol","first-page":"22","article-title":"Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis","volume":"8","author":"Gambhir","year":"2010"},{"key":"b41","series-title":"PLoS Negl Trop Dis","first-page":"e0010231","article-title":"Positive-case follow up for lymphatic filariasis after a transmission assessment survey in Haiti","volume":"16","author":"Hast","year":"2022"},{"key":"b42","series-title":"Validation of Elimination of Lymphatic Filariasis as a Public Health Problem","year":"2017"},{"key":"b43","series-title":"BMC Med","first-page":"141","article-title":"Programmatic options for monitoring malaria in elimination settings: Easy access group surveys to investigate Plasmodium falciparum epidemiology in two regions with differing endemicity in Haiti","volume":"18","author":"Druetz","year":"2020"},{"key":"b44","series-title":"World Malaria Report 2021","year":"2021"},{"key":"b45","series-title":"Infect Dis Poverty","first-page":"39","article-title":"Prevalence of malaria and lymphatic filariasis in bateyes of the Dominican Republic","volume":"8","author":"Keys","year":"2019"},{"key":"b46","series-title":"Am J Trop Med Hyg","first-page":"2139","article-title":"Rapid screening for non-falciparum malaria in elimination settings using multiplex antigen and antibody detection: Post hoc identification of Plasmodium malariae in an infant in Haiti","volume":"104","author":"Van den Hoogen","year":"2021"},{"key":"b47","series-title":"PLoS Negl Trop Dis","first-page":"e0005610","article-title":"Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis","volume":"11","author":"Harris","year":"2017"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/111\/3_Suppl\/article-p81.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/111\/3_Suppl\/article-p81.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/111\/3_Suppl\/article-p81.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T19:55:17Z","timestamp":1725479717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/111\/3_Suppl\/article-p81.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":47,"journal-issue":{"issue":"3_Suppl"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.23-0765","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,3]]}}}